In this 10-part series, we profile doctors who are working passionately to combat racism, change the system and improve patient care for racialized communities.
The regulatory filings include clinical data from a trial of 30,000 participants in the U.S. and Mexico, which found 100% protection against moderate and severe disease and 90.4% efficacy overall, Novavax said.
But when Marcia's condition deteriorated and she needed palliative care about a year ago, Marcaccio reached out for help from Ontario's home care system.
